Background Ulcerative Colitis (UC) is an inflammatory condition affecting the colon with an
incidence of approximately 10‐20 per 100,000 per year. No existing intervention is effective …

Background Ulcerative colitis is an inflammatory condition affecting the colon, with an
annual incidence of approximately 10 to 20 per 100,000 people. The majority of people with …

Background Ulcerative colitis is an inflammatory condition affecting the colon, with an
annual incidence of approximately 10 to 20 per 100,000 people. The majority of people with …

Background Ulcerative colitis is a chronic relapsing disease characterised by diffuse
mucosal inflammation limited to the colon. Current maintenance treatments have multiple …

This review examined the effectiveness of probiotics and anti-inflammatory drugs in patients
with ulcerative colitis and concluded that the two treatment options appeared to have similar …

The intestinal microbiota is one of the key players in the etiology of ulcerative colitis.
Manipulation of this microflora with probiotics and prebiotics is an attractive strategy in the …

Background Whether probiotics are beneficial at all stages of treatment in inflammatory
bowel disease or superior to placebo remains controversial. Methods Two reviewers …

AIM: To evaluate the induction of remission and maintenance effects of probiotics for
ulcerative colitis. METHODS: Information was retrieved from MEDLINE, EMBASE, and the …

Background Ulcerative colitis (UC) and Crohn's disease (CD) are inflammatory bowel
diseases (IBD). Evidence implicates disturbances of the gastrointestinal microbiota in their …

Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory diseases of the
gastrointestinal tract affecting millions of patients worldwide. The gut microbiome partly …